catalog number :
MBS212463
products full name :
MOUSE ANTI HUNTINGTIN
products short name :
HUNTINGTIN
other names :
huntingtin; Huntingtin; huntingtin; huntington disease protein; huntingtin; Huntington disease protein; HD protein
other gene names :
HTT; HTT; HD; IT15; HD; IT15; HD protein
uniprot entry name :
HD_HUMAN
reactivity :
Human, Mouse, Rabbit
form :
Purified. Purified IgG - liquid
concentration :
IgG concentration 1.0mg/ml
storage stability :
Store at 4 degree C or at -20 degree C if preferred. This product should be stored undiluted. Storage in frost free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use. Shelf Life: 18 months from date of despatch.
tested application :
Immunohistology Frozen*, Immunoprecipitation (IP), Western Blot (WB)
app notes :
Immunohistology - Frozen: Application Note: Increased cytoplasmic staining, relative to nuclear, has been reported using formaldehyde as a fixative compared with acetone/methanol, see Wilkinson et al.
other info1 :
Perservative Stabilisers: 0.09% Sodium Azide
other info2 :
Histology Positive Control Tissue: Brain. Buffer Solution: Phosphate buffered saline
products description :
Mouse anti Huntingtin antibody, clone HDA3E10 reacts with an epitope corresponding to the HDA region (amino acids 1171 - 1177) of the huntingtin protein. Mouse anti Huntingtin antibody, clone HDA3E10 detects a 350KD band on western blots but also detects smaller degradation products of huntingtin. The combined use of clone HDA3E10 (MBS212463) HDC8A4 (MBS212465) and HDB4E10 (MBS212464) demonstrate that huntingtin is enriched in neuronal cells in the brain.
ncbi acc num :
NP_002102.4
ncbi gb acc num :
NM_002111.7
ncbi mol weight :
347,603 Da
ncbi pathways :
Direct P53 Effectors Pathway 137939!!EGFR1 Signaling Pathway 198782!!Huntington's Disease Pathway 83100!!Huntington's Disease Pathway 512
ncbi summary :
Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range in the number of trinucleotide repeats has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2008]